Tumor immunology top 10 list

被引:7
作者
Finn, Olivera J. [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15262 USA
关键词
D O I
10.1111/j.1600-065X.2008.00623.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
引用
收藏
页码:5 / 8
页数:4
相关论文
共 48 条
[1]
The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance [J].
Allavena, Paola ;
Sica, Antonio ;
Garlanda, Cecilia ;
Mantovani, Alberto .
IMMUNOLOGICAL REVIEWS, 2008, 222 :155-161
[2]
Cancer vaccines for established cancer: how to make them better? [J].
Andrews, Daniel M. ;
Maraskovsky, Eugene ;
Smyth, Mark J. .
IMMUNOLOGICAL REVIEWS, 2008, 222 :242-255
[3]
Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy? [J].
Apte, Ron N. ;
Voronov, Elena .
IMMUNOLOGICAL REVIEWS, 2008, 222 :222-241
[4]
Immunogenic HER-2/neu peptides as tumor vaccines [J].
Baxevanis, CN ;
Sotiriadou, NN ;
Gritzapis, AD ;
Sotiropoulou, PA ;
Perez, SA ;
Cacoullos, NT ;
Papamichail, M .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2006, 55 (01) :85-95
[5]
Her-2/neu-derived peptide epitopes are also recognized by cytotoxic CD3+CD56+ (natural killer T) lymphocytes [J].
Baxevanis, CN ;
Gritzapis, AD ;
Tsitsilonis, OE ;
Katsoulas, HL ;
Papamichail, M .
INTERNATIONAL JOURNAL OF CANCER, 2002, 98 (06) :864-872
[6]
Cheever MAM, 2008, IMMUNOL REV, V222, P357, DOI 10.1111/j.1600-065X.2008.00604.x
[7]
Monoclonal antibody therapy for B-cell malignancies [J].
Cheson, Bruce D. .
SEMINARS IN ONCOLOGY, 2006, 33 (02) :S2-S14
[8]
Paradoxical roles of the immune system during cancer development [J].
de Visser, KE ;
Eichten, A ;
Coussens, LM .
NATURE REVIEWS CANCER, 2006, 6 (01) :24-37
[9]
Anti-HER2/neu IgG3-(IL-2) and anti-HER2/neu IgG3-(GM-CSF) promote HER2/neu processing and presentation by dendritic cells:: Implications in immunotherapy and vaccination strategies [J].
Dela Cruz, JS ;
Trinh, KTR ;
Chen, HW ;
Ribas, A ;
Morrison, SL ;
Penichet, ML .
MOLECULAR IMMUNOLOGY, 2006, 43 (06) :667-676
[10]
Disis ML, 1999, CLIN CANCER RES, V5, P1289